Preview

An Analysis of the Pharmaceutical Industry using Porter's Five Force model, PEST, BCG Matrix and predicting future prospects.

Powerful Essays
Open Document
Open Document
3088 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
An Analysis of the Pharmaceutical Industry using Porter's Five Force model, PEST, BCG Matrix and predicting future prospects.
"In 1897, Felix Hoffmann created a new industry. He found a way of adding a cluster of two extra carbon and five extra hydrogen atoms to a substance extracted from willow bark. The result is known to chemists as acetylsalicylic acid. To everyone else it is known as aspirin. It turned Bayer, the dye-maker Hoffmann worked for, into the world's first modern drug company." Geoffrey Carr, The Alchemists, The Economist - Feb 19th 1998

Today's Pharmaceutical Industry is characterized by several important factors that influence the business environment in which each company operates:

·Severe competition from capitally strong competitors

·Strict government regulations

·Long approval wait time

·Technology as an important factor

·Lower levels of marketing and customer relations in comparison to other markets

- Sales share of the world's top 75 prescription medicines 2002

Source

IMS

Industry Environment Analysis

In 1997, the $65 billion industry was composed of three strategic groups: patented prescription drugs, generic prescription drugs and over-the-counter drugs. Firms such as Merck, SmithKline, Eli Lilly and others produced various types of brand name drugs. Pharmaceutical companies spent huge amounts of money on development. The products produced by companies are very innovative. Many companies market up to ten (10) "blockbuster" drugs each year. These drugs have a patent life of seventeen (17) years. However, since it takes on average twelve (12) years to get the drug to market, manufactures have only five (5) years in the market to recoup their heavy research and development costs. After the patent expires we move to our next strategic group; the generic prescription drug makers.

Pharmaceutical R&D expenditure in the UK

Pharma R&D expenditure £ millionPharma R&D as a % of output1

1972427

198554614

19901,14017

19911,23917

19921,42017

19931,70721

19941,91820

19951,90319

19962,07820

19972,25121

19982,37623

19992,78523

20002,84625

20013,04024

You May Also Find These Documents Helpful

  • Powerful Essays

    Prescription drugs whose patents have expired are highly elastic; however, prescription drugs whose patents still exist are highly inelastic. Many consumers will substitute generic brands for drugs that have had their patents expire. These generic drugs can be produced at a much lower cost and yet still contain the active ingredients and FDA approval to their brand name equivalent. As a result, supply increases along with demand and puts downward pressure on price. Because there are no substitutes for patented drugs, consumers have no choice but to pay the higher prices determined by supply and demand…

    • 1538 Words
    • 7 Pages
    Powerful Essays
  • Best Essays

    David H. Austin (October 2006). Research and Development in the Pharmaceutical Industry. Received From http://www.cbo.gov/ftpdocs/76xx/doc7615/10-02-DrugR-D.pdf.…

    • 4398 Words
    • 18 Pages
    Best Essays
  • Good Essays

    Brand name price responses to market entry begins by assuming that the brand name producer is a dominant firm that incorporates price responses of generics to its own pricing decisions while the generic producers are fringe firms that take the brand name price as given (Frank & Salkever, 1992). Pharmaceutical medication is often viewed as being inappropriately over priced and often makes it necessary for lower income consumers to choose generic brands rather than the branded drugs. The larger pharmaceutical manufacturers spend massive amount of money in order to conduct research and development so that the drug will meet the standards set by the Food and Drug Administration (FDA). Once a drug patent is approved and hits the market, the competition can duplicate the drug for a lower price, therefore making the generic brands significantly cheaper than the originally patented brand.…

    • 743 Words
    • 3 Pages
    Good Essays
  • Good Essays

    The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale, product differentiation, government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct competition with one another,…

    • 1056 Words
    • 5 Pages
    Good Essays
  • Best Essays

    Pfizer Industry Review

    • 4325 Words
    • 18 Pages

    Since the 1950s, the global pharmaceutical industry has evolved from “…a collection of several hundred, small, barely profitable firms to as small group of large, highly profitable firms” (Younkin, 2008, para. 1). This evolution has resulted in an oligopoly market structure with a few large firms, and significant barriers to market entry. In the last 20 years, pharmaceutical consolidation has continued with both vertical and horizontal mergers that have further shrunk the market. Since 1995, Pfizer has merged with five pharmaceutical firms (Industry Brief, 2003) in an attempt to increase its research and development divisions and to offset declines in new product development; increases in generic competition; and the emergence of bio-pharmaceutical firms (BCC Research, 2004). Although pharmaceutical firms no longer view mega mergers as “…a cure-all for [their] innovation drought” (Simons, 2007, para. 1), this trend towards consolidation is expected to continue, with firms focusing “…on targeted acquisitions and alliances with smaller…more innovative drug makers and biotechs” (Simons, 2007, para. 10).…

    • 4325 Words
    • 18 Pages
    Best Essays
  • Powerful Essays

    Merck Business Analysis

    • 1943 Words
    • 8 Pages

    The global pharmaceutical market is likely to undergo a wide variety of changes with new competition arising in India, China, Malaysia, South Korea, and Indonesia. This new competition has a growing economy and has made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States.…

    • 1943 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    Health Care Benefits

    • 424 Words
    • 2 Pages

    Patents and rights of exclusivity allow pharmaceutical companies to hold essentially a monopoly over their drug for a period of time. As a result of this, generic medications can only be produced by other pharmaceutical companies, after a pharmaceutical patent runs out. This time period where pharmaceutical companies hold the patent over their drug is essential to spur the companies to invest in new medications. Without this period, drug innovation would almost halt. No company would be willing to spend the money without the guarantee of reconciliation. Because of this it would be foolish just to shorten the time allowed for a pharmaceutical company to hold a patent. However If we could make research and development of new drugs cheaper, it would still be worth it. By changing the guidelines researchers must follow, we could not only shorten the time but also the cost of bringing a new medication to the marketplace. We could then shorten the period in which pharmaceutical companies could hold their patents, and still have pharmaceutical companies come out on top. This in turn would allow generic drugs to be released sooner, and lower the cost of medication. By working closely in pharmaceuticals I would like to lead major reforms in the pharmaceutical industry to lower the cost of research and development of new medications, in order to make medications cheaper and more accessible to every person who are forced to make these choices, and maybe someday my grandma could buy chocolate, and stay on her…

    • 424 Words
    • 2 Pages
    Good Essays
  • Powerful Essays

    In the past several years some critical changes have been taking place in the pharmaceutical industry which included encouragement of generic prescriptions by the formularies, the exclusive listing of a single drug for a particular therapeutic prescription, enablement of bulk discount rate negotiation by health care insurers, and the minimization of the number of drugs to be put in the formularies. These changes pressured the pharmaceutical manufacturers to reduce the…

    • 1583 Words
    • 7 Pages
    Powerful Essays
  • Good Essays

    Pfizer - Financial Analysis

    • 2555 Words
    • 11 Pages

    Pfizer (NYSE: PFE) is involved in the development, manufacturing and marketing of pharmaceutical products. The industry is intensely competitive. There are a few unique characteristics. Pharmaceutical products have long and expensive development periods – upwards of ten years and $100 million depending on the nature of the drug and the scope of the clinical trials process. In order to encourage companies to engage in innovation, companies are given lengthy patent protection for their drugs upon receiving regulatory approval. This allows them to charge monopoly rents so that they may recover the development cost. A product brought to market is often highly lucrative, so success in the industry depends largely on the firm’s ability to bring product to market and capitalize on the monopoly rents.…

    • 2555 Words
    • 11 Pages
    Good Essays
  • Powerful Essays

    A useful synthesis of acetylsalicylic acid was developed in 1893, patented in 1899, marketed under the trade name of “aspirin” by the Bayer Company in…

    • 1461 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    Pharmaceutical companies spend a lot of time in developing and manufacturing drugs. One type of drug could take ten to twenty years after testing the drug, being approved by the FDA, and distribution. Makes one wonder just how much money they put into the discovery of…

    • 627 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Analysis on Merck

    • 1280 Words
    • 6 Pages

    The new technologies and law made it easier for companies to market drugs. FDA allowed the direct to consumer advertising of prescription drugs. Newly developed drugs were put in the market within a matter of months and companies focused more on marketing and advertising their drugs. Smaller companies collaborated or merged with Merck’s competitors to enhance technology, drug discovery and development. Pharmaceutical companies actually doubled their sales force between 1995 and 2001 to 80,000 sales rep. In the early 1990s, the MCOs began taking control and restricting the type, prices and number of drugs on their formularies or approved list. The MCOs presence and control on pharmaceutical companies led to slow sales and growth.…

    • 1280 Words
    • 6 Pages
    Good Essays
  • Good Essays

    Lipitor Marketing

    • 782 Words
    • 4 Pages

    The success of this strategy hinges on the inertia of doctors, patients and the other stakeholders (pharmacists, HMOs, governments). When their motivation to switch to the newly-available generic is low, either because of low financial incentives or strong attachment to the brand or to the value of brand equity for funding research and development, such a strategy can deliver high profitability, at least over the short term. Over the longer term, however, the profitability of this strategy depends on the elasticity of the other still-patent protected drugs to the additional promotional investments.…

    • 782 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Drug Discovery KPIs

    • 1572 Words
    • 55 Pages

    KPIs for Drug Discovery STRATEGIC IMPERATIVES • • Product Quality Benchmarking among the competitors CRITICAL SUCCESS FACTORS • • • Sustainable quality High Standards Optimal Pricing Strategy KEY PERFORMANCE INDICATORS • • • • • Pioneers in Quality and Standards • • Positive results of Quality Control and Assurance Market leaders in Quality • • • Customer retention= % of old customers of the total customers Total volume of Sales each year as compared to the previous years New Customers Continued government approvals and number of new licenses granted Credibility Ratings-­‐ Statistics obtained from US FDA and other regulatory bodies. Market Share in developed economies Volume of recommendations from physicians and hospitals • • High Quality and Efficient Operations Production, Distribution & Supply • • • • Effective and Efficient Drug discovery and design • • • • • Focused Trained Personnel Innovative & technology driven strategy Integration with other business units • • • • • • Cross BU sales Volume of new distributors Customer satisfaction surveys Inventory turns Reduced lead times Efficient R&D schedule…

    • 1572 Words
    • 55 Pages
    Powerful Essays
  • Powerful Essays

    Term Paper Otc

    • 947 Words
    • 4 Pages

    The world market for Over The Counter pharmaceutical products was estimated at $51.45 billion dollars in 1995 and was expected to sustain a compound annual growth rate of 7 percent through the year 2004. Among the factors that are driving this growth: more educated consumers taking control of their health care, governments and managed care organizations trying to reduce health care expenditures, and pharmaceutical companies trying to expand the product life cycle of key brands.…

    • 947 Words
    • 4 Pages
    Powerful Essays